Clinical Benefit of Eplerenone in Patients With Mild Symptoms of Systolic Heart Failure Already Receiving Optimal Best Practice Background Drug Therapy: Analysis of the EMPHASIS-HF Study
Circulation. Heart failure - United States
doi 10.1161/circheartfailure.112.000173
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2013
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)